New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives

New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives

Introduction: Lung cancer (LC) is the most common neoplasm worldwide, and 85% of these tumors are classified as non-small cell lung cancer (NSCLC). LC treatment was initially restricted to cytotoxic chemotherapy—platinum compounds associated with 3rd generation cytotoxic agents (paclitaxel, gemcitab...

Full description

Bibliographic Details
Main Authors: Ramon Andrade de Mello, Nathália Moisés Neves, Hakaru Tadokoro, Giovanna Araújo Amaral, Pedro Castelo-Branco, Victor André de Almeida Zia
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Clinical Medicine
Subjects:
non-small-cell lung cancer
target therapy
tyrosine kinase inhibitors
ALK inhibitors
immunotherapy
Online Access:https://www.mdpi.com/2077-0383/9/11/3543

Internet

https://www.mdpi.com/2077-0383/9/11/3543

Similar Items